Lenalidomide Impurity A is a structurally related synthetic byproduct arising from the alkylation step in lenalidomide production. It retains the 2-chlorophthalimide core but lacks the glutarimide side chain, featuring a terminal piperidine-1-ylamino group instead of the fully substituted glutarimide moiety. This impurity exhibits a truncated pharmacophore with reduced steric bulk compared to the parent API. Its primary application is as a reference standard for HPLC-based quantification of process-related impurities in lenalidomide drug substance characterization.
On RequestC1C2=C(C=CC=C2[N+](=O)[O-])C(=O)N1C(CCC(=O)O)C(=O)N
InChI=1S/C13H13N3O6/c14-12(19)10(4-5-11(17)18)15-6-8-7(13(15)20)2-1-3-9(8)16(21)22/h1-3,10H,4-6H2,(H2,14,19)(H,17,18)
MUVQMLOEDIDSDJ-UHFFFAOYSA-N